Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy

By sjmartinez • July 11, 2022

Lechner MG, Cheng MI, Patel AY, Hoang AT, Yakobian N, Astourian M, Pioso MS, Rodriguez ED, McCarthy EC, Hugo W, Angell TE, Drakaki A, Ribas A, Su MA. Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy. J Immunol. 2022 Jul 11:ji2200244. doi: 10.4049/jimmunol.2200244. Epub ahead of print. PMID: 35817515.

Tags: Endocrinology, Hematology/Oncology, Publications

Markers of mitochondrial function and oxidative metabolism in skeletal muscle do not display intrinsic circadian regulation in female mice

Fitzgerald LS, Reynoso Spurrier CS, Lau N, Melamed M, Burnett LA, Meyer GA, Gui C, Hevener AL, Sanford JA, Schenk S. Markers of mitochondrial function[...]

TRAF6 integrates innate immune signals to regulate glucose homeostasis via Parkin-dependent and Parkin-independent mitophagy

Levi-D'Ancona E, Walker EM, Zhu J, Deng Y, Sidarala V, Stendahl AM, Reck EC, Henry-Kanarek BA, Lietzke AC, Chai B, Pasmooij MB, Hubers DL, Basrur[...]

Late Diagnosis of Pregnancy in a Transmasculine Patient on Testosterone: A Case Report and Patient Perspective

Agrawal N, Kanin M, Binder HL, Havard A, Grock S. Late Diagnosis of Pregnancy in a Transmasculine Patient on Testosterone: A Case Report and Patient[...]